Oppenheimer & Co. Inc. decreased its position in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 84.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,921 shares of the basic materials company's stock after selling 27,103 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Cameco were worth $203,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Hurley Capital LLC bought a new position in Cameco during the 4th quarter worth approximately $27,000. Bank Julius Baer & Co. Ltd Zurich bought a new position in Cameco during the 4th quarter worth approximately $28,000. Copia Wealth Management bought a new position in Cameco during the 4th quarter worth approximately $39,000. Ameriflex Group Inc. bought a new position in Cameco during the 4th quarter worth approximately $40,000. Finally, Larson Financial Group LLC boosted its stake in Cameco by 37.4% during the 4th quarter. Larson Financial Group LLC now owns 830 shares of the basic materials company's stock worth $43,000 after acquiring an additional 226 shares during the last quarter. Institutional investors own 70.21% of the company's stock.
Cameco Stock Performance
Shares of CCJ stock opened at $73.02 on Friday. The company's fifty day simple moving average is $59.33 and its 200-day simple moving average is $50.85. The company has a quick ratio of 1.26, a current ratio of 2.70 and a debt-to-equity ratio of 0.15. The firm has a market cap of $31.79 billion, a PE ratio of 182.55 and a beta of 1.03. Cameco Corporation has a 12 month low of $35.00 and a 12 month high of $75.42.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings data on Thursday, May 1st. The basic materials company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.07). The business had revenue of $549.58 million during the quarter, compared to the consensus estimate of $890.07 million. Cameco had a return on equity of 4.47% and a net margin of 7.50%. The business's revenue for the quarter was up 24.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.13 EPS. Equities research analysts expect that Cameco Corporation will post 1.27 EPS for the current fiscal year.
Analyst Ratings Changes
CCJ has been the topic of several recent analyst reports. Raymond James Financial reissued an "outperform" rating on shares of Cameco in a research note on Wednesday, June 18th. Glj Research reaffirmed a "buy" rating and issued a $75.27 price target on shares of Cameco in a research note on Thursday, June 12th. Scotiabank reaffirmed an "outperform" rating on shares of Cameco in a research note on Wednesday, May 14th. Stifel Nicolaus began coverage on shares of Cameco in a research note on Wednesday, March 12th. They issued a "buy" rating on the stock. Finally, UBS Group reaffirmed a "buy" rating on shares of Cameco in a research note on Tuesday, June 10th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and three have issued a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $80.65.
Read Our Latest Stock Report on CCJ
Cameco Profile
(
Free Report)
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
